End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
179,700 KRW | +0.56% | +0.62% | -10.82% |
Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
Apr. 17 | Celltrion, Inc. authorizes a Buyback Plan. | CI |
Chart calendar Celltrion, Inc.
Upcoming events on Celltrion, Inc.
Past events on Celltrion, Inc.
2024-02-28 | Q4 2023 Earnings Release |
2024-01-09 | JPMorgan Healthcare Conference |
2023-11-06 | Q3 2023 Earnings Release |
2023-09-12 | Roadshow - Day - 2 |
2023-09-11 | Roadshow - Day - 1 |
2023-09-11 03:35 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
2023-08-24 03:00 am | Investor Meeting |
2023-08-17 03:30 am | Investor Meeting |
2023-05-07 | Q1 2023 Earnings Release |
2023-03-19 | Q4 2022 Earnings Release |
2022-11-13 | Q3 2022 Earnings Release |
2022-08-15 | Interim 2022 Earnings Release |
2022-05-15 | Q1 2022 Earnings Release |
2022-02-15 | FY 2021 Earnings Release |
2021-11-09 | Q3 2021 Earnings Release |
2021-08-16 | Interim 2021 Earnings Release |
2021-05-11 | Q1 2021 Earnings Release |
2021-02-21 | FY 2020 Earnings Release |
2020-03-29 | FY 2019 Earnings Release |
2019-11-13 | Q3 2019 Earnings Release |
Past dividends on Celltrion, Inc.
2023-12-26 | Annual 500 KRW |
2022-12-27 | Annual 375 KRW |
2021-12-28 | Annual 750 KRW |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 1 128 1 108 1.81% | 1 849 1 860 -0.58% | 1 891 1 898 -0.36% | 2 284 2 367 -3.53% | 2 176 2 369 -8.11% | 3 428 |
EBITDA Billions KRW | Released Forecast Spread | 537 539 -0.23% | 891 899 -0.89% | 972 947 2.66% | 874 981 -10.95% | 0,00 1 024 - | 883 |
EBIT Billions KRW | Released Forecast Spread | 378 401 -5.65% | 712 754 -5.55% | 754 757 -0.48% | 647 751 -13.82% | 651 836 -22.03% | 649 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 379 397 -4.61% | 651 748 -12.99% | 747 823 -9.29% | 626 799 -21.59% | 671 834 -19.5% | 638 |
Net income Billions KRW | Released Forecast Spread | 298 322 -7.6% | 511 576 -11.17% | 575 603 -4.63% | 533 622 -14.21% | 536 703 -23.81% | 505 |
EPS KRW | Released Forecast Spread | 2 153 2 215 -2.78% | 3 586 4 005 -10.46% | 4 031 4 164 -3.2% | 3 855 4 308 -10.52% | 0,00 4 850 - | 2 497 |
Announcement Date | 19/02/20 | 22/02/21 | 16/02/22 | 03/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 601 627 -4.2% | 551 500 10.23% | 596 544 9.66% | 646 585 10.32% | 511 606 -15.67% | 597 600 -0.42% | 524 606 -13.58% | 672 646 4.09% | 383 581 -34.19% | 723 | 775 | 930 | 1 046 | 969 |
EBITDA Billions KRW | Released Forecast Spread | 131 | 200 | 265 | 350 | 445 | |||||||||
EBIT Billions KRW | Released Forecast Spread | 219 233 -5.86% | 142 189 -24.7% | 199 185 7.29% | 214 202 5.61% | 101 204 -50.77% | 182 194 -6.11% | 183 193 -5.26% | 268 224 19.62% | 18,4 186 -90.07% | 7,68 | 53,1 | 242 | 342 | 321 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 145 216 -32.76% | 227 193 17.37% | 217 206 5.24% | 48,5 186 -73.88% | 208 182 14.21% | 190 180 5.68% | 283 224 26.02% | |||||||
Net income Billions KRW | Released Forecast Spread | 120 175 -31.1% | 119 129 -8.12% | 183 133 37.8% | 167 159 4.54% | 64,5 160 -59.54% | 167 152 9.92% | 148 156 -5.57% | 222 174 27.63% | 1,05 167 -99.37% | 8,00 | 49,3 | 201 | 268 | 296 |
EPS KRW | Released Forecast Spread | 1 162 791 46.78% | 470 781 -39.79% | 1 155 977 18.26% | 1 034 1 013 2.12% | 1 561 1 097 42.29% | |||||||||
Announcement Date | 16/02/22 | 12/05/22 | 05/08/22 | 09/11/22 | 03/03/23 | 08/05/23 | 14/08/23 | 07/11/23 | 29/02/24 | - | - | - | - | - |
2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-23 | CUREVAC N.V.: Q4 2023 Earnings Release |
2024-04-23 | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
2024-04-23 | EVOTEC SE: Q4 2023 Earnings Release |
2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
2024-04-24 | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
2024-04-24 | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
2024-04-24 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
2024-04-24 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Past sector events for Celltrion, Inc.
Today | SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.: Q1 2024 Earnings Release (Projected) |
Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q1 2024 Earnings Release |
Today | HANGZHOU BIO-SINCERITY PHARMA-TECH CO.,LTD.: Q4 2023 Earnings Release |
2024-04-22 04:15 pm | MEDPACE HOLDINGS, INC.: Q1 2024 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A068270 Stock
- Calendar Celltrion, Inc.